Position in NVCR
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$824,372
+$226,061 QoQ
Shares Held
54,414
-0.9% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#3
of 15 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $14,694,487 across 9 Medical Devices names. NVCR ranks #7 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
12,844 | $4,043,804 | |
| 2 | BSX |
Boston Scientific Corp
|
93,021 | $3,970,136 | |
| 3 | MDT |
Medtronic plc
|
28,669 | $2,242,775 | |
| 4 | ABT |
Abbott Laboratories
|
12,902 | $1,170,727 | |
| 5 | DXCM |
Dexcom Inc
|
14,350 | $966,472 | |
| 6 | EW |
Edwards Lifesciences Corp
|
9,292 | $840,554 | |
| 7 | NVCR |
NovoCure Ltd
This page
|
54,414 | $824,372 | |
| 8 | IRTC |
iRhythm Holdings, Inc.
|
3,521 | $418,822 |
All Filings in NVCR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $824,372 | 54,414 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $598,311 | 54,891 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $701,387 | 54,245 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $533,983 | 41,330 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $432,896 | 24,320 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||